Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03410030
Title Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) (AA NABPLAGEM)
Acronym AA NABPLAGEM
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors HonorHealth Research Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.